UBS analyst Joshua Chan maintains ABM Indus (NYSE:ABM) with a Neutral and raises the price target from $55 to $56.
- Headlines
- UBS Maintains Neutral on ABM Indus, Raises Price Target to $56
UBS Maintains Neutral on ABM Indus, Raises Price Target to $56
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
21:42
Yealink Network Technology: Shareholder plans to reduce their stake by no more than 0.99% of the company's shares.
Yealink+0.55%
21:42
Gotion High-tech: Achieving comprehensive breakthroughs in the Passenger Vehicle, Commercial Vehicle, and Light Vehicle markets by 2025.
Gotion High-tech+0.41%
21:30
China Securities Co.,Ltd.: Investment strategy for the Traditional Chinese Medicine and Pharmaceutical Commerce Industry in 2025.
China Securities Co.,Ltd.+2.28%